How Airway Obstruction and Respiratory Distress Can Impact Pediatric Patients Versus Adult Patients With Congenital Plasminogen Deficiency
Pharmacy Times® interviewed Charles Nakar, MD and Amy Shapiro, MD, of the Indiana Hemophilia & Thrombosis Center, on how airway obstruction and respiratory distress can impact pediatric patients versus adult patients.
Pharmacy Times® interviewed Charles Nakar, MD and Amy Shapiro, MD, both pediatric hematologist-oncologists at the Indiana Hemophilia & Thrombosis Center, on their presentation at the 62nd ASH Annual Meeting and Exposition. The presentation discusses research into acute airway obstruction in 4 pediatric patients with congenital plasminogen deficiency treated with intravenous plasminogen replacement therapy under an expanded access protocol.
In this video, Nakar and Shapiro explain how airway obstruction and respiratory distress can impact pediatric patients versus adult patients, and whether there are unique considerations for the treatment of pediatric patients.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025